Emi Noguchi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 6
- Cancer Diagnosis and Treatment 3
- Cancer Treatment and Pharmacology 2
-
- Sarcoma Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Kan Yonemori (48 shared papers)Tatsunori Shimoi (39 shared papers)Yasuhiro Fujiwara (35 shared papers)Kenji Tamura (22 shared papers)Akihiko Shimomura (23 shared papers)Masayuki Yoshida (11 shared papers)Kazuki Sudo (32 shared papers)Mayu Yunokawa (11 shared papers)
- Journals
- BMC Cancer (6 papers)Breast Cancer (4 papers)Annals of Oncology (3 papers)Oncology (3 papers)Gynecologic Oncology (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Emi Noguchi
62 papers receiving 796 citations
Peers
Comparison fields: 5 of 76
- Oncology 372
- Cancer Research 102
- Pulmonary and Respiratory Medicine 220
- Obstetrics and Gynecology 30
- Pathology and Forensic Medicine 69
Countries citing papers authored by Emi Noguchi
This map shows the geographic impact of Emi Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Noguchi more than expected).
Fields of papers citing papers by Emi Noguchi
This network shows the impact of papers produced by Emi Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Noguchi. The network helps show where Emi Noguchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Emi Noguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 122 | |
| 2 | 2021 | 59 | |
| 3 | 2019 | 38 | |
| 4 | 2018 | 38 | |
| 5 | 2021 | 36 | |
| 6 | 2017 | 36 | |
| 7 | 2021 | 30 | |
| 8 | 2021 | 27 | |
| 9 | 2020 | 26 | |
| 10 | 2018 | 25 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 22 | |
| 13 | 2017 | 17 | |
| 14 | 2022 | 14 | |
| 15 | 2020 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2024 | 13 | |
| 18 | 2017 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2024 | 12 |
About Emi Noguchi
Emi Noguchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Obstetrics and Gynecology and Rheumatology, having authored 65 papers that have together received 811 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Diagnosis and Treatment (3 papers), Cardiac tumors and thrombi (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (372 citations), Cancer Research (102 citations), Pulmonary and Respiratory Medicine (220 citations), Obstetrics and Gynecology (30 citations) and Pathology and Forensic Medicine (69 citations). Emi Noguchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kan Yonemori, Tatsunori Shimoi, Yasuhiro Fujiwara, Kenji Tamura, Akihiko Shimomura, Masayuki Yoshida, Kazuki Sudo, Mayu Yunokawa, Chikako Shimizu and Takayuki Kinoshita. Their work appears in journals such as BMC Cancer, Breast Cancer, Annals of Oncology, Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.